• 106 Citations
  • 3 h-Index
1981 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Thomas W Froehlich is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Melanoma Medicine & Life Sciences
Progressive Multifocal Leukoencephalopathy Medicine & Life Sciences
Metagenomics Medicine & Life Sciences
Metabolomics Medicine & Life Sciences
Antiphospholipid Syndrome Medicine & Life Sciences
DNA Nucleotidylexotransferase Medicine & Life Sciences
Digoxin Medicine & Life Sciences
Firearms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1981 2019

  • 106 Citations
  • 3 h-Index
  • 5 Article
  • 1 Letter

Impact of a Cancer Urgent Care Clinic on Regional Emergency Department Visits

Hong, A. S., Froehlich, T. W., Clayton Hobbs, S., Lee, S. C. & Halm, E. A., Jun 1 2019, In : Journal of oncology practice. 15, 6, p. e501-e509

Research output: Contribution to journalArticle

Ambulatory Care Facilities
Hospital Emergency Service
Neoplasms
Hospitalization
Registries
2 Citations (Scopus)

Ibrutinib use complicated by progressive multifocal leukoencephalopathy

Hsiehchen, D., Arasaratnam, R. J., Raj, K., Froehlich, T. W. & Anderson, L., Oct 1 2018, In : Oncology (Switzerland). 95, 5, p. 319-322 4 p.

Research output: Contribution to journalArticle

Progressive Multifocal Leukoencephalopathy
T-Lymphocytes
Polyomavirus
Demyelinating Diseases
B-Cell Chronic Lymphocytic Leukemia
2 Citations (Scopus)

Antiphospholipid syndrome associated with combined immune checkpoint inhibitor therapy

Gupta, A., Shah, U., Khine, H., Vandergriff, T. & Froehlich, T., 2017, In : Melanoma Research. 27, 2, p. 171-173 3 p.

Research output: Contribution to journalLetter

Antiphospholipid Syndrome
Therapeutics
5 Citations (Scopus)

Digoxin Plus Trametinib Therapy Achieves Disease Control in BRAF Wild-Type Metastatic Melanoma Patients

Frankel, A. E., Eskiocak, U., Gill, J. G., Yuan, S., Ramesh, V., Froehlich, T. W., Ahn, C. & Morrison, S. J., Apr 1 2017, In : Neoplasia (United States). 19, 4, p. 255-260 6 p.

Research output: Contribution to journalArticle

Digoxin
Melanoma
Mitogen-Activated Protein Kinase Kinases
Cardenolides
Therapeutics
61 Citations (Scopus)
Metagenomics
Metabolomics
Firearms
Melanoma
Bacteroides